Gyre Therapeutics Inc. (GYRE)
NASDAQ · Healthcare
Gyre Therapeutics Inc. Income Statement 2009–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2018 | Dec 2017 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||
| Revenue | 116.6M | 105.8M | 113.5M | 102.3M | 7.3M | 20.9M | 6,000 | 1.0M | 275,000 | 3.6M | 57.9M | 97.6M | 85.7M | 25.1M |
| Gross Profit | 111.2M | 101.9M | 108.8M | 97.5M | — | — | — | — | — | — | — | — | — | 24.4M |
| Profitability | ||||||||||||||
| Operating Income | 11.5M | 16.2M | -67.2M | 9.2M | -87.9M | -57.4M | -33.8M | -21.8M | -7.5M | -10.1M | -8.1M | -9.7M | 13.1M | -40.3M |
| EBITDA | 14.0M | 17.7M | -66.2M | 10.3M | -87.6M | -57.2M | -33.7M | -21.6M | -6.8M | -9.1M | -5.9M | -7.3M | 15.1M | -38.5M |
| Net Income | 9.9M | 17.9M | -85.5M | 4.3M | -87.9M | -56.2M | -30.1M | -21.6M | -6.6M | -10.0M | -7.0M | -8.5M | 10.9M | -39.4M |
| Per Share Data | ||||||||||||||
| EPS (diluted) | $0.02 | $0.05 | $-1.41 | $0.03 | $-2.87 | — | — | — | — | — | $-0.21 | $-0.27 | $0.36 | $-1.54 |
| Shares Outstanding (dil.) | 103M | 102M | 66M | 76M | 31M | 22M | 12M | 6M | 0M | 34M | 33M | 32M | 30M | 26M |
Gyre Therapeutics Inc. Income Statement — FAQ
Gyre Therapeutics Inc. (GYRE) income statement over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see GYRE's income statement history?
The chart and table above show Gyre Therapeutics Inc.'s income statement by year and by quarter, including the growth rate.